Hutch News

Hutch News

Stories tagged 'immunotherapy research'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 13, 2016

Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response.

View story >


New clues to treating deadly skin cancer

Small clinical trial finds two forms of immunotherapy may be better than one for treating metastatic melanoma

June 6, 2016 | By Rachel Tompa / Fred Hutch News Service

Matthew Flood, a retired EMT from the Tacoma Fire Department, is one of 10 patients with metastatic melanoma treated with an experimental combination of immunotherapies between 2011 and 2013. In a study published today in the Journal of Clinical Oncology, the research team described the small clinical trial and how the patients have fared in the years following their treatment. Flood is now in complete remission five years after receiving the combo immunotherapy.

View story >


Dramatic remissions seen in immunotherapy trial of blood cancer patients

Experimental, living T-cell therapy shows promise for treating advanced disease, making immunotherapy a ‘pillar’ of cancer care

Feb. 16, 2016 | By Andrea Detter / Fred Hutch News Service

Many patients with advanced blood cancers who are receiving experimental, “living” immunotherapy as part of a clinical trial are experiencing sustained remissions, according to preliminary results of the ongoing study at Fred Hutchinson Cancer Research Center.

View story >


From building toys to developing cures

At 80, transplant scientist Dr. Rainer Storb can't stop tinkering with — and solving — medical puzzles

Dec. 21, 2015 | By Susan Keown / Fred Hutch News Service

Dr. Rainer Storb loves seeing and catching up with his former patients - men and women saved by his own research. He's 80 with big research goals still ahead.

View story >


'Results you just don't expect to see': Many blood cancer patients in complete remission after immunotherapy

High rates of complete remission reported in patients with advanced blood cancers in preliminary results from ongoing immunotherapy trial

Dec. 7, 2015 | By Susan Keown / Fred Hutch News Service

Many patients with late-stage blood cancers receiving an experimental T-cell therapy went into complete remission, according to preliminary research results from a Fred Hutchinson Cancer Research Center trial presented this week at the annual meeting of the American Society of Hematology.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 19, 2015 | By Fred Hutch News Service staff

More than a dozen Fred Hutch scientists and staff participated in the ninth annual Life Sciences Research Weekend Nov. 6-8 at Pacific Science Center in Seattle. Read about this and more Good News at Fred Hutch.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.